Publisher's Synopsis
The issue provides a valuable, updated resource on PAH, including topics such as epidemiology; assessing response to therapy; pathology; genetics and mediators; diagnosis; standard therapies; endothelin receptor antagonists prostanoids, and nitric oxide pathway in the treatment of PAH; combination therapy and new types of agents; surgical therapies; porto-pulmonary hypertension; and pulmonary hypertension associated with respiratory diseases, left heart disease, congenital heart disease, and thromboembolic disease. This issue provides a definitive handbook on the most important topics in PAH.
